Sex-Dependent Vascular Responses to Atorvastatin Across Multiple Arterial Beds in a Mouse Model of Marfan Syndrome

Patrick Hunt1, Kimberly Huynh1, Brikena Gusek2

  • 1College of Osteopathic Medicine, Midwestern University, Glendale, AZ 85308, USA.

Cells
|July 13, 2026
PubMed

Insights

Atorvastatin therapy improved arterial stiffness and reduced aortic dilation in Marfan syndrome (MFS) mice. However, it caused sex-specific blood pressure changes and varied effects on different arteries, highlighting heterogeneous systemic impacts.

Area of Science:

  • Cardiovascular Research
  • Genetics and Disease Modeling
  • Pharmacology

Background:

  • Marfan syndrome (MFS), caused by fibrillin-1 gene mutations, leads to aortic aneurysm and widespread vascular dysfunction.
  • Statins show promise in MFS models, but their systemic effects beyond the aorta are not well understood.

Purpose of the Study:

  • To investigate the impact of chronic atorvastatin on vascular structure and hemodynamics in multiple arterial beds in a mouse model of Marfan syndrome.

Main Methods:

  • Utilized the Fbn1^C1041G/+^ mouse model of MFS, treating mice with atorvastatin from 4 weeks to 6 months of age.
  • Employed high-frequency ultrasound to assess vascular parameters in the aorta, carotid artery, and cerebral artery.
  • Analyzed sex-specific responses to atorvastatin treatment in both MFS and control mice.

Main Results:

  • Atorvastatin attenuated aortic root dilation and reduced aortic pulse wave velocity (PWV) in MFS mice.
  • Carotid artery analysis showed reduced wall thickness and PWV, but no improvement in wall strain.
  • Atorvastatin increased blood pressure in MFS mice, normalizing it towards control levels, with sex-specific hemodynamic changes observed in the cerebral arteries.

Conclusions:

  • Chronic atorvastatin exerts systemic yet heterogeneous vascular effects in MFS, improving arterial stiffness and remodeling across multiple beds.
  • Observed sex-specific hemodynamic responses warrant further investigation for targeted MFS therapies.

Related Concept Videos